A lower level of antibodies against the Omicron virus variant is triggered by COVID-19 vaccines, researchers said in a new study.
Using blood samples from people who received two doses of the Oxford-AstraZeneca vaccine or the Pfizer-BioNTech jab, researchers with the University of Oxford found “a substantial fall” in neutralizing antibodies, with evidence of some people failing to have any.
